SScience Read More Immune signaling pathway protects newborn heart cells from injuryAugust 17, 2026 Researchers at the University Hospital of Bonn (UKB) and the University of Bonn have identified a previously unknown…
SScience Read More Ten-million-person study links semaglutide to lower COVID-19 mortalityJuly 31, 2026 After accounting for major health differences between semaglutide users and non-users, researchers identified a striking mortality association that…
HHealth Read More Semaglutide and tirzepatide linked to fewer alcohol-related hospital visitsJuly 24, 2026 A large US health-record study suggests newer GLP-1 drugs may reduce alcohol-related acute-care visits, but the findings remain…
HHealth Read More Newer GLP-1 medications may reduce alcohol-related hospitalization riskJuly 22, 2026 Use of newer GLP-1 receptor agonists (semaglutide or tirzepatide) for obesity or diabetes by people with alcohol-use disorder…
HHealth Read More Popular diabetes drugs do not alter the risk of developing a blinding eye conditionJuly 17, 2026 An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs) – a type of…
HHealth Read More First-in-class experimental CAR T-cell therapy shows promise against solid tumorsJuly 3, 2026 Researchers with the Charbonneau Cancer Institute at the University of Calgary and McMaster University have identified a unique…
SScience Read More Lysosomal protein stabilizes mitochondria to prevent severe heart failureJune 16, 2026 A new study published in Engineering has uncovered a regulatory mechanism linking lysosomal function to mitochondrial stability in…
HHealth Read More Physical activity declines after starting GLP-1 obesity treatmentsJune 14, 2026 Adults with obesity losing weight with glucagon-like peptide-1 (GLP-1) receptor agonist medications significantly decreased their physical activity, which…
MMedication Read More The next goal for weight loss drugs? Fewer injectionsJune 9, 2026 For millions of people taking weight loss drugs, the next breakthrough may not be more weight loss. It…
TTechnology Read More INDIGO Biosciences expands reporter assay capabilities with new Transrepression Assay ServicesMay 12, 2026 INDIGO Biosciences today announced the launch of its Transrepression Assay Services, expanding the company’s cell-based reporter assay capabilities…
HHealth Read More Kenyan bat coronavirus uses human CEACAM6 to enter cells, raising spillover concernsApril 24, 2026 A newly characterized bat coronavirus can latch onto a human cell receptor found in the lung, giving scientists…
HHealth Read More Investigating microglia’s role in Alzheimer’s pathologyMarch 2, 2026 Announcing a new article publication for BIO Integration journal. Alzheimer’s disease (AD) is a neurodegenerative disorder and the…